Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

The impeachment debate around HHS Secretary RFK Jr. is dominating headlines, but a healthcare policy expert argues it's a distraction from the bigger picture. Whether Kennedy stays or goes, the U.S. healthcare system's core problems — affordability, access, and agency integrity — remain unsolved. The real test for Congress is whether it can hold the system accountable for the care Americans can actually get and afford.
As Democrats in the newly elected Congress discuss investigating and potentially impeaching HHS Secretary Robert F. Kennedy Jr., a healthcare management professor is urging a more grounded conversation. Scott Phillips, who has worked across private healthcare, military medicine, the VA, and health insurance, argues that removing Kennedy would not fix the structural problems plaguing American healthcare — affordability, access, and the integrity of federal health agencies.
Phillips acknowledges some merit in Kennedy's focus on chronic disease prevention and nutrition, but warns that patients who need insulin or specialty care can't wait for long-term prevention investments to pay off. He also raises concerns about Kennedy's scientific claims — particularly his suggestion of a link between acetaminophen use during pregnancy and autism — noting that large, well-controlled studies have not supported that connection. On agency reform, Phillips supports scrutiny of conflicts of interest at the FDA, CDC, and NIH, but argues that weakening agencies without a clear plan for maintaining essential functions is not a solution.
Key Takeaways:
Why it matters: With a new Congress taking shape and healthcare policy in flux, this piece offers a practical framework for evaluating reform — one focused on patient outcomes and system accountability rather than political theater.